(S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID
- CAS No.251565-85-2
- Chemical Name:(S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID
- CBNumber:CB5114898
- Molecular Formula:C20H24O7S
- Formula Weight:408.47
- MOL File:251565-85-2.mol
- Melting point 83-85°C
- Boiling point 611℃
- Density 1.278
- Flash point 324℃
- storage temp. 2-8°C
- solubility Chloroform (Slightly), Methanol (Slightly)
- form Solid
- pka 3.62±0.10(Predicted)
- color White
- Merck 14,9177
- FDA UNII 6734037O3L
- UNSPSC Code 12352200
- NACRES NA.77
-
Symbol(GHS)
- Signal wordWarning
- Hazard statements H302
- Precautionary statements P280-P305+P351+P338
(S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID Chemical Properties,Usage,Production
- Chemical Properties White Solid
- Uses Dual -acting peroxisome proliferator-activated receptor (PPAR) a and agonist. Antidiabetic
- Biological Activity Tesaglitazar is a potent and specific dual PPARα/γ agonist th at improves insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.
-
in vivo
Tesaglitazar (0.3-10 μmol/kg; po; once daily; 104 weeks) induces subcutaneous stromal sarcomas (fibrosarcomas) in Wistar Hannover Galas rats, and also induces a variety of non-neoplastic changes, such as cardiac hypertrophy and liver changes[1].
Tesaglitazar (1, 10 μmol/kg; po; once daily; 2 or 12 weeks) in Wistar Hannover Galas rats, sustained stimulation of DNA synthesis, increased BrdU-labeled cells[1].
Tesaglitazar (50 nmol/kg; sc; once daily; 14 days) reduced body weight, food intake, fasting blood glucose and insulin levels, improved insulin sensitivity and glucose metabolism, and had no significant effect on renal function in the male C57BL/6J diet-induced obesity (DIO) mouse model[2].
Tesaglitazar (5 or 100 nmol/kg; sc; single dose) induced an acute deterioration in glucose tolerance at a high dose (100 nmol/kg), but a low dose (5 nmol/kg) reduced body weight, food intake and fasting blood glucose levels and improved glucose tolerance[2] in the DIO mouse model[2].
Tesaglitazar (10-20 μg/kg; intraperitoneal injection; single dose) significantly restored the mechanical paw withdrawal threshold (PWT) in the Streptozotocin (HY-13753)-induced diabetic neuropathy pain model in rats without affecting blood glucose levels[3].Animal Model: Wistar Hannover Galas rats (6-8 weeks old; carcinogenicity model)[1] Dosage: 0.3, 1, 3, 10 μmol/kg (dissolved in 5mM sodium hydrogen carbonate buffer solution, pH 8.5) Administration: Oral gavage, once daily, 104 weeks Result: Induced subcutaneous mesenchymal sarcomas (fibrosarcomas) in both male and female rats (10 μmol/kg).
Caused various non-neoplastic changes, such as myocardial hypertrophy, liver changes, and alterations in multiple organ systems. - storage Desiccate at RT
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:sales@coreychem.com
- Country:China
- ProdList:29858
- Advantage:58
-
Supplier:
- Tel:8485655694
- Email:sales@alchempharmtech.com
- Country:United States
- ProdList:63687
- Advantage:58
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32222
- Advantage:58
-
Supplier:
- Tel:+8615604608665<br/>15604608665
- Email:dominicguo@gk-bio.com
- Country:CHINA
- ProdList:9414
- Advantage:58
-
Supplier:
- Tel:+86-0571-88938639<br/>+8617705817739
- Email:info@dycnchem.com
- Country:China
- ProdList:52849
- Advantage:58
-
Supplier:
- Tel: +8615250961469
- Email:2571773637@qq.com
- Country:China
- ProdList:9691
- Advantage:58
-
Supplier:
- Tel:+1-708-310-1919<br/>+1-13798911105
- Email:sales@invivochem.cn
- Country:United States
- ProdList:6391
- Advantage:58
-
Supplier:
- Tel:+86-25-58227606<br/>+86-15305155328
- Email:sales@dogechemical.com
- Country:China
- ProdList:4128
- Advantage:58
-
Supplier:
- Tel:+86-0571-85585865<br/>+8613336024896
- Email:CB@aromsyn.com
- Country:China
- ProdList:19183
- Advantage:58
-
Supplier:
- Tel: +8618058761490
- Email:info@gihichemicals.com
- Country:China
- ProdList:49984
- Advantage:58
- Sulfur & Selenium Compounds
- Pharmaceuticals
- Chiral Reagents
- Intermediates & Fine Chemicals
- Drug Intermediates
- 抑制剂
- 生化试剂
- 医药中间体
- C20H24O7S
- 替格列扎,10 MM DMSO 溶液
- 化合物 T17044
- 替格列扎
- (S)-2-乙氧基-3-{4-[2-(4-甲磺酰基苯基)-乙氧基-苯基]-丙酸
- (S)-2-乙氧基-3-[4-[2-(4-甲磺酰基氧基苯基)乙氧基]苯基]丙酸
- 251565-85-2
- Tesaglitazar, 10 mM in DMSO
- (2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
- Tesaglitizar
- Benzenepropanoic acid, α-ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]-, (αS)-
- 2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
- Galida
- (aS)-α-Ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]benzenepropanoic Acid
- Benzenepropanoic acid, a-ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]-, (aS)-
- Galid
- AZ 242
- AR-H 039242XX
- (aS)-a-Ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]benzenepropanoic Acid
- AR-H 039242
- (S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoic Acid
- TESAGLITAZAR
- (S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID
- Benzenepropanoic acid, .alpha.-ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]-, (.alpha.S)-
- (S)-2-Ethoxy-3-(4-(4-((Methylsulfonyl)oxy)phenethoxy)phenyl)propanoic acid
- (S)-2-ethoxy-3-[4-(2-{4-Methanesulphonyloxyphenyl}ethoxy)phenyl]propanoic acid
- (alphaS)-alpha-Ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]benzenepropanoic acid
- (αS)-α-Ethoxy-4-[2-[4-[(Methylsulfonyl)oxy]phenyl]ethoxy]benzenepropanoic Acid
- 2-Ethoxy-3-{4-[2-(4-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionicacid